Service is in preparation Official β release coming soon. Some features are still being adjusted.

Investical Earnings & investing calendar Earnings & investing calendar
/
AAstellas Pharma Inc. logo
4503TSE Prime

Astellas Pharma Inc.

アステラス製薬 Yahoo Finance

Recent & upcoming events

Aug 5
Earnings 2:00
Q1 earnings announcement (scheduled)
Add to Google Calendar
Jun 18
Shareholder meeting Time TBD
Shareholders' meeting
Add to Google Calendar
Apr 27
Earnings 2:00
FY earnings announcement (scheduled)
Add to Google Calendar
Sep 27
Est.
Dividend Time TBD
Last day with rights (interim)
Add to Google Calendar
Sep 28
Est.
Ex-dividend Time TBD
Ex-rights date (interim)
Add to Google Calendar
Nov 11
Est.
Earnings 1:00 approx.
Q2 earnings
Add to Google Calendar
2027
Feb 24
Est.
Earnings 1:00 approx.
Q3 earnings
Add to Google Calendar
Mar 28
Est.
Dividend Time TBD
Last day with rights (year-end)
Add to Google Calendar
Mar 29
Est.
Ex-dividend Time TBD
Ex-rights date (year-end)
Add to Google Calendar
Jun 2
Est.
Earnings 2:00 approx.
Full-year earnings
Add to Google Calendar
Sep 8
Est.
Earnings 2:00 approx.
Q1 earnings
Add to Google Calendar

KPI highlights

FY26
Revenue ¥2.14T YoY +11.9%
Operating income ¥382.63B margin 17.9%
Net income ¥291.54B YoY +474.5%
EPS ¥163 YoY +474.1%
P/E —
ROE 17.4% Equity ratio 51% Typical equity ratios vary a lot by industry. Banks, brokerages, and other financial companies tend to run lower ratios because leverage (using other people's capital) is core to their business model — a low ratio there isn't a sign of financial weakness.

Company guidance

FY2027/03 Company-issued full-year guidance (from earnings report) / %=vs prior FY
Revenue ¥2.22T +3.8%
Operating income ¥395.00B +3.2%
Net income ¥300.00B +2.9%
EPS ¥167 +2.9%

Quarterly fundamentals

Income & cash flow
Quarter FY23 Q2FY23 Q3FY23 Q4FY24 Q1FY24 Q2FY25 Q2
Revenue ¥374.99B¥392.15B¥421.93B¥414.60B——
Operating income ¥45.05B¥-3.22B¥18.87B¥-45.90B——
Net income ¥33.13B¥-1.46B¥14.51B¥-33.28B——
Operating CF ——————

Ownership over time

Share of total shares outstanding (disclosed major holdings + undisclosed)（2021–2026）

国内機関 34.2%海外機関 4.8%未開示 61.1%202120222023202420252026
国内機関海外機関未開示・浮動株

「国内機関」は信託銀行の名義口座（年金・パッシブ・一部海外資本を含む）を集計し、実質保有者へは分解していません。分類は開示名称からの推定です。

Top shareholders — rank & share

日本マスタートラスト信託銀行株式会社 19%日本マスタートラスト信託銀行株式会社 (信託口)株式会社日本カストディ銀行 (信託口 7.2%株式会社日本カストディ銀行 (信託口)日本生命保険相互会社 (常任代理人　 2.9%日本生命保険相互会社 (常任代理人　日本マスタートラスト信託銀行株式会社)ＪＰモルガン証券株式会社 1.7%ＪＰモルガン証券株式会社ＪＰ ＭＯＲＧＡＮ ＣＨＡＳＥ ＢＡ 1.5%ＪＰ ＭＯＲＧＡＮ ＣＨＡＳＥ ＢＡＮＫ ３８５７８１ (常任代理人　株式会社みずほ銀行決済営業部)ＳＭＢＣ日興証券株式会社 1.2%ＳＭＢＣ日興証券株式会社野村信託銀行株式会社 (投信口) 1.2%野村信託銀行株式会社 (投信口)株式会社日本カストディ銀行 (信託口 1%株式会社日本カストディ銀行 (信託口４)202120222023202420252026

Top shareholders — actual figures (as of 2026)

Holder Shares held Ratio Source
日本マスタートラスト信託銀行株式会社 (信託口) 343,200,000 19.0% Yuho (EDINET)
株式会社日本カストディ銀行 (信託口) 130,182,000 7.2% Yuho (EDINET)
日本生命保険相互会社 51,588,000 2.9% Yuho (EDINET)
STATE STREET BANK AND TRUST COMPANY 505001 38,405,000 2.1% Yuho (EDINET)
JPモルガン証券株式会社 30,057,000 1.7% Yuho (EDINET)
JP MORGAN CHASE BANK 385781 26,465,000 1.5% Yuho (EDINET)
SMBC日興証券株式会社 22,484,000 1.2% Yuho (EDINET)
野村信託銀行株式会社 (投信口) 22,218,000 1.2% Yuho (EDINET)
STATE STREET BANK AND TRUST COMPANY 505103 21,360,000 1.2% Yuho (EDINET)
株式会社日本カストディ銀行 (信託口4) 18,927,000 1.0% Yuho (EDINET)

Source：EDINET（大株主の状況）　Classification inferred from disclosed names

F-Score (Piotroski)

8/9

Checks financial health against 9 criteria and shows how many are met as a fraction (more ✓ marks is healthier). Items with no data are shown as “—” — they're simply excluded from judgment, not counted against the score.

✓ Positive ROA ROA 8.2%
✓ Positive operating cash flow ¥560.19B
✓ ROA improved YoY 1.5% → 8.2%
✓ Operating CF exceeds net income (accrual quality) OCF ¥560.19B / net income ¥291.54B
✓ Equity ratio improved* Substitute for the original “decrease in long-term debt” 45.3% → 51.3%
✓ Current ratio improved 1.13× → 1.17×
✓ No dilution (shares outstanding did not increase) 1,809,663,000 → 1,809,663,000
✗ Gross margin improved 81.7% → 80.9%
✓ Asset turnover improved 0.57× → 0.60×

This score is reference information based on our own financial metrics. It is NOT a credit rating issued by a credit rating agency under Article 66-27 of the Financial Instruments and Exchange Act, and is NOT investment advice or a recommendation. Make investment decisions at your own responsibility.

Fact checklist

FY26
Equity ratio 51.3%
Current ratio 1.2×
Years of positive operating CF 10 of last 10 yrs
Payout ratio 38%
Latest fiscal year result Profit (net income ¥291.54B)

Performance history

Last 10 years
0.0兆円0.5兆円1.1兆円1.6兆円2.1兆円 FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26

Income & assets

Unit: ¥100M
Item FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
Revenue 13,11713,00313,06313,00812,49512,96215,18616,03719,12321,392
Operating income ——2,4392,4401,3611,5571,3302554103,826
Ordinary income ——————————
Net income 2,1871,6472,2231,9541,2061,2419871705072,915
Total assets 18,20918,58218,97623,18222,73623,32424,56535,69633,39535,670
Equity 12,71812,68312,58412,89213,86114,60315,08015,96015,13318,290

A “—” means data wasn't available for that period — it's not a display error or an unusual value.

Indicators & cash flow

Unit: ¥100M
Item FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
EPS ¥104¥81¥115¥104¥65¥67¥54¥10¥28¥163
ROE 17.3%13.0%17.6%15.3%9.0%8.7%6.7%1.1%3.3%17.4%
Operating CF 2,3563,1262,5862,2203,0682,5743,2781,7251,9455,602
Investing CF -734-1,218-418-3,898-819-624-845-8,458-894-667
Financing CF -1,662-2,034-2,3371,811-2,295-2,163-1,9566,141-2,614-4,048
FCF 1,6221,9082,169-1,6782,2491,9502,433-6,7331,0514,935

Source: EDINET (Annual Securities Report) (fetched 2026-08-29) *Some metrics supplemented from additional sources

Key financial metrics

High ROE ✓ 3-year revenue growth ✓ Dividend grower ✓

Sector positioning

Relative standing within the sector
Is this information incorrect?

Data provided by Twelve Data